Management of Serum Iron Level of 272 µg/dL
A serum iron level of 272 µg/dL alone is insufficient to guide management—you must immediately measure transferrin saturation (TSAT) and serum ferritin to determine if iron overload exists and whether treatment is indicated.
Diagnostic Algorithm
The isolated serum iron value of 272 µg/dL requires contextualization through additional testing:
Step 1: Measure TSAT and Ferritin Immediately
According to the most recent EASL guidelines, provisional iron overload is diagnosed when BOTH of the following are present 1:
- TSAT >50% in males and post-menopausal women (>45% in pre-menopausal women)
- Ferritin >300 µg/L in males and post-menopausal women (>200 µg/L in pre-menopausal women)
Step 2: If Iron Overload is Confirmed
Order HFE genetic testing to identify C282Y homozygosity, which accounts for >95% of hereditary hemochromatosis cases 1.
Step 3: Assess for End-Organ Damage
Check the following to determine disease severity:
- Liver enzymes (ALT, AST) to assess hepatic involvement
- Liver elastography or imaging if ferritin >1000 µg/L to identify advanced fibrosis 2
- Fasting glucose and HbA1c for diabetes screening
- Joint examination for arthropathy
- Cardiac assessment if symptomatic or in severe/early-onset cases 1
Treatment Decision Framework
If C282Y Homozygote with Confirmed Iron Overload:
Initiate therapeutic phlebotomy immediately 3:
- Remove 500 mL blood weekly or biweekly as tolerated
- Check hemoglobin/hematocrit before each phlebotomy
- Do not allow hemoglobin to fall >20% from baseline
- Monitor ferritin every 10-12 phlebotomies (approximately every 3 months)
- Induction phase: <50 µg/L
- Maintenance phase: 50-100 µg/L
If Ferritin <1000 µg/L with Normal Liver Enzymes:
Proceed directly to phlebotomy without liver biopsy 3. The treatment is safe, inexpensive, and prevents progression to cirrhosis, diabetes, and hepatocellular carcinoma—complications that dramatically worsen morbidity and mortality 3.
If Advanced Disease is Present:
Exercise caution with phlebotomy frequency in patients with cardiac involvement, as rapid iron mobilization increases risk of sudden death from arrhythmias 3.
Critical Caveats
Avoid vitamin C supplementation during treatment—it accelerates iron mobilization beyond transferrin's capacity, creating toxic free radical activity 3.
No dietary iron restriction is necessary—dietary modification only affects 2-4 mg/day compared to 200-250 mg removed per phlebotomy 3.
If cirrhosis develops before treatment, continue lifelong HCC surveillance even after iron depletion, as HCC accounts for 30% of hemochromatosis-related deaths 3. However, HCC is exceptionally rare in non-cirrhotic patients, emphasizing the importance of early treatment 3.
If Iron Overload is NOT Confirmed
If TSAT and ferritin are normal despite the elevated serum iron of 272 µg/dL, this represents a transient elevation or laboratory variation—no treatment is indicated. Serum iron fluctuates significantly and is not a reliable standalone marker 1.